Orthopedic Funding on Pace to Accelerate in 2024

We wrote in early 2024 that orthopedic funding announcements had slowed in recent years. Lingering market disruption and changing investor attitudes drove 2023 funding activity to its lowest level in nearly a decade.

However, orthopedic investments through the first half of 2024 have the industry on pace for a big leap.

We tracked 21...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us